$9.72
+0.0100 (+0.103%)
At Close: Jun 03, 2026
Globus Medical Climbs 18.12% From Q2 Exit - Beats EPS By $0.18; But Let's Not Jump In Just Yet (NYSE:GMED)
06:22pm, Tuesday, 11'th Aug 2020
25.74% price returns over the past month with earnings surprise of $45.3 million on Q2 results. 18.31% CAGR growth in FCF with additional 18% reinvestment in net working capital bolsters consensus FCF
Did Hedge Funds Make The Right Call On Orthofix Medical Inc (OFIX) ?
06:22pm, Tuesday, 11'th Aug 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Head to Head Analysis: Orthofix Medical (NASDAQ:OFIX) versus GenMark Diagnostics (NASDAQ:GNMK)
10:58pm, Sunday, 09'th Aug 2020
GenMark Diagnostics (NASDAQ:GNMK) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of th
Orthofix (OFIX) Reports Q2 Loss, Tops Revenue Estimates
04:55pm, Thursday, 06'th Aug 2020
Orthofix (OFIX) delivered earnings and revenue surprises of 26.25% and 35.94%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Orthofix Reports Second Quarter 2020 Results | | IT Business Net
12:02pm, Thursday, 06'th Aug 2020
Net sales of $73.1 million, a decrease of 37% compared to prior year on a reported and constant currency basis Record Motion Preservation sales quarter of $3.6 million in the U.S., an increase of 24%
Orthofix Reports Second Quarter 2020 Results
11:00am, Thursday, 06'th Aug 2020
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the second quarter ended June 30, 2020. Net sales were $73.1 million, earnings per share ("EPS") was ($0.96) and adjusted E
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Global Spine Biologics Market: Growth, Trends & Forecasts (2020-2025) - ResearchAndMarkets.com
12:00am, Tuesday, 04'th Aug 2020
The
Orthofix to Present at the Canaccord Genuity Growth Conference on August 13
08:03pm, Monday, 03'rd Aug 2020
Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek will present at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13,
Orthofix to Present at the Canaccord Genuity Growth Conference on August 13
12:00am, Monday, 03'rd Aug 2020
Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek will present at the Canaccord Genuity 40t
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Earnings Preview: Orthofix (OFIX) Q2 Earnings Expected to Decline
04:33pm, Thursday, 30'th Jul 2020
Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Orthofix Schedules Second Quarter 2020 Earnings Release and Conference Call for August 6, 2020
11:00am, Monday, 27'th Jul 2020
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the second quarte
Orthofix Schedules Second Quarter 2020 Earnings Release and Conference Call for August 6, 2020
12:00am, Monday, 27'th Jul 2020
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans
Orthofix JuniOrtho Plating System Gets Regulatory Clearances
12:29pm, Tuesday, 21'st Jul 2020
Orthofix (OFIX) rides high on dual regulatory clearances for its deformity correction system, thus solidifying its pediatric orthopedics portfolio.
Sign In
Buy OFIX